Medicover AB (publ)
MCOV-B
Rank in Stocks
#3955
Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ)... Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.
Share Price
$27.18
Market Cap
$4.13B
Change (1 day)
1.13%
Change (1 year)
-1.05%
Country
SE
Trade Medicover AB (publ) (MCOV-B)
Category
Healthcare
P/B ratio for Medicover AB (publ) (MCOV-B)
P/B ratio as of 2026 TTM: 0
According to Medicover AB (publ) latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Medicover AB (publ) from 2014 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2025 | 5.74 | 6.57% |
| 2024 | 5.39 | 33.25% |
| 2023 | 4.04 | 3.52% |
| 2022 | 3.90 | -61.93% |
| 2021 | 10.26 | 99.50% |
| 2020 | 5.14 | 18.89% |
| 2019 | 4.32 | 47.88% |
| 2018 | 2.92 | 17.22% |
| 2017 | 2.49 | -64.25% |
| 2016 | 6.98 | -34.38% |
| 2015 | 10.63 | 2.37% |
| 2014 | 10.39 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| -15.9433 | - |
US
|
|
| - | - |
DE
|
|
| 4.8701 | - |
US
|
|
| 8.8163 | - |
SA
|
|
| 4.6058 | - |
BR
|
